Navigation Links
Ron Peele Named President of STB Lifesaving Technologies(R)
Date:2/2/2010

ROCKVILLE, Md., Feb. 2 /PRNewswire/ -- STB Lifesaving Technologies® announced today the hiring of Ron Peele as President, to lead its transition from an R&D stage initiative, to a commercial business.  Mr. Peele has spent the past 25 years building companies as both an investor and operating executive.  He joins STB® from Revolution Health, where he was a founding investor and CFO, working closely with Steve Case from its inception to merger with Everyday Health, where it's now the largest online health company.  Prior to that, Mr. Peele helped launch and build the AOL/Time Warner venture capital group, making strategic investments in some of the industry's most successful start-up companies.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100202/NE48377 )

STB®, which stands for "stop the bleeding," is developing a suite of products to control serious and life-threatening hemorrhage. Successful animal studies with both military and commercial partners, and published data from the American Red Cross, have demonstrated STB®'s flagship product, the Fibrin Adhesive STat or FAST® dressing, to be functionally superior.

"At the core of STB® is our collective mission to prevent deaths from bleeding, and the latest data on our flagship product is compelling and promising," said Peele.  "I've helped build many companies over the years, but this is my first opportunity to build something that can actually save people's lives.

"I had been working in an advisory role with founding investors Richard Moscarello and Jody Bellar, and the inventor of the technology, Dr. Martin MacPhee. During that time together we realized we all share the same vision for STB®.  Now Martin and his team of scientists can focus exclusively on the clinical and product development, while we focus on building strategic relationships and expanding resources to enable us to bring this product to patients who need it."

About STB®

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland.  STB® is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STB®'s products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies


'/>"/>
SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aurora Hospitals Named Among the Nations Best
2. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company
3. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
4. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
5. Biovista Inc. Named Top Innovator in Life Sciences
6. Fujirebio Diagnostics Named Life Sciences Company of the Year
7. Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation
8. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
9. MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
10. Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
11. IPC The Hospitalist Companys Philip Vaidyan, M.D. Named a Top Hospitalist of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):